Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/12/17
End: 12/30/28
Due: 12/30/29
Phase: N/A
Priority: Normal
Start: 12/13/23
End: 12/14/31
Due: 12/14/32
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase II Study of Combined Chemotherapy With Arsenic Trioxide in Stage 4/M Neuroblastoma | NCT03503864 | Yang Li | user2@example.com | None | 2017-06-12 | 2028-12-30 | 2029-12-30 | - | - | 2025-07-14 |
| Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer | NCT06088030 | Yang Li | user2@example.com | None | 2023-12-13 | 2031-12-14 | 2032-12-14 | - | - | 2025-07-14 |